H1F0 (Histone H1.0) is a linker histone variant found in cells at terminal stages of differentiation or with low rates of cell division. It plays a crucial role in the condensation of nucleosome chains into higher-order chromatin structures . As a member of the H1 histone family, H1F0 is essential for regulating chromatin structure and transcriptional activity . Research indicates that linker histones like H1F0 exhibit ultrahigh affinity binding to nucleosomes, suggesting their critical role in genome organization and gene expression regulation .
The H1F0 (Ab-101) Antibody is a polyclonal antibody raised in rabbits against a peptide sequence around the site of Lysine 101 derived from Human Histone H1.0 . It recognizes both human and rat H1F0 proteins . The antibody is supplied in liquid form, purified using antigen affinity methods, and stored in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative .
| Specification | Description |
|---|---|
| Product Code | CSB-PA010087OA101nme1HU |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Species Reactivity | Human (Homo sapiens), Rat (Rattus norvegicus) |
| Immunogen | Peptide sequence around site of Lys (101) derived from Human Histone H1.0 |
| Applications | ELISA, WB, IHC, IF, ChIP |
| Recommended Dilutions | WB: 1:50-1:500, IHC: 1:20-1:200, IF: 1:1-1:10 |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze-thaw cycles |
| Form | Liquid (Non-conjugated) |
The H1F0 (Ab-101) Antibody can be used in multiple experimental applications including Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Enzyme-Linked Immunosorbent Assay (ELISA), and Chromatin Immunoprecipitation (ChIP) . It is particularly valuable for studying histone dynamics, chromatin structure, and epigenetic modifications. When used for ChIP experiments, this antibody can help identify genomic regions where H1F0 is bound, providing insights into its role in gene regulation and chromatin organization .
Research has shown that cellular fractionation methods yield better results than nuclei isolation when studying linker histones like H1F0 . For optimal isolation:
Fractionate cells to separate cytosolic and nuclear components
Process the fractions to extract histones using mild acid extraction methods
Analyze the extracted histones using liquid chromatography-mass spectrometry (LC-MS)
This approach has been demonstrated to give less nuclear contamination and higher histone content than preparations by nuclei isolation alone . The method is particularly useful for monitoring the movement of histone H1 variants (including H1F0) across cellular compartments in response to experimental treatments or during different cellular states .
For analyzing H1F0-nucleosome interactions, Förster resonance energy transfer (FRET) combined with confocal single-molecule spectroscopy has proven effective . A recommended protocol involves:
Attaching donor and acceptor fluorophores at positions 113 and 194 in H1F0, spanning its disordered C-terminal region
Monitoring the binding to reconstituted nucleosomes based on the 197-base-pair (bp) 601 Widom sequence
Observing changes in FRET efficiency (⟨E⟩) that indicate compaction of H1F0 upon binding
Using nanosecond fluorescence correlation spectroscopy (nsFCS) to analyze the dynamics of H1F0 when bound to nucleosomes
This approach reveals that H1F0 shows pronounced long-range chain dynamics on the 100-ns timescale even when bound to nucleosomes, indicating that the disordered regions retain significant mobility when associated with chromatin .
When performing Western Blot with H1F0 (Ab-101) Antibody, researchers should consider:
The predicted molecular weight of H1F0 is approximately 21 kDa with observed band at 21 kDa in validated samples
Positive control samples like rat spleen tissue have been validated to show specific binding
Using appropriate secondary antibodies (e.g., goat polyclonal to rabbit IgG) at optimized dilutions (1/50000 has been validated)
Including appropriate blocking steps to minimize non-specific binding
If multiple bands appear, consider:
Post-translational modifications of H1F0 that may alter its migration pattern
Potential degradation products
Cross-reactivity with other histone variants
Optimizing antibody concentration (recommended dilution range: 1:50-1:500)
Research has revealed several factors that influence H1F0-nucleosome binding dynamics:
Electrostatic interactions: H1F0 contains highly positively charged regions that interact with the negatively charged DNA. The ionic strength of the experimental buffer significantly affects binding affinity and should be carefully controlled .
Competing proteins: Highly negatively charged disordered proteins (like prothymosin α) can efficiently invade the H1F0-nucleosome complex and displace H1F0 via competitive substitution. Consider the presence of such factors in your experimental system .
Conformational dynamics: H1F0 shows pronounced long-range chain dynamics when bound to nucleosomes, with local segments continuously disengaging and reengaging in non-specific electrostatic interactions with DNA. These dynamics can be experimentally measured using fluorescence techniques like nsFCS .
Linker DNA properties: The structure and length of linker DNA affects H1F0 binding. Using reconstituted nucleosomes with defined linker DNA properties allows for controlled experiments .
To control these factors experimentally, researchers can modulate buffer composition, use competitive binding assays, and employ fluorescence lifetime analysis to assess the dynamic nature of the interactions .
Recent research has shown that H1 protein-mediated DNA condensation dramatically reduces HIV-1 integration, suggesting that features inherent to open chromatin are preferred for viral DNA integration . To investigate this mechanism:
Use preintegration complex (PIC)-mediated integration assays with both naked DNA and nucleosomal DNA
Examine the effect of histone modifications (particularly H3K36me3) on integration efficiency
Assess the impact of H1F0 and other linker histones on integration patterns
Map integration sites using primers designed for HIV-1 genome detection (e.g., using primer pairs targeting U5 of HIV-1 genome)
A table of useful primers for such experiments includes:
| Primer | Sequence (5′–3′) | Binding site | Use |
|---|---|---|---|
| PIC-mediated integration (REV) | GTGCGCGCTTCAGCAAG | U5 of HIV-1 genome | PIC assay (ALL) |
| Gag-PVI (REV) | GTTCCTGCTATGTCACTTCC | HIV-1 Gag sequence | Detection of viral integration |
| ALU (FWD) | GCCTCCCAAAGTGCTGGGATTACAG | Alu repeat in human genome | PIC assay with chromatin/genomic DNA |
| NPS-147-FWD | CTGGAGAATCCCGGTGC | 5′ end of Widom 601 NPS | PIC assay with Widom substrates |
These experiments can reveal how H1F0 and chromatin structure influence HIV-1 integration site selection, with implications for understanding viral latency and developing potential therapeutic strategies .
Cellular fractionation combined with LC-MS analysis has revealed that soluble linker histone phosphorylation increases as cells reach mitosis . To investigate H1F0 phosphorylation patterns:
Perform cellular fractionation to isolate H1F0 from different cell cycle phases
Use LC-MS to analyze post-translational modifications, focusing on phosphorylation sites
Compare phosphorylation patterns between chromatin-bound and soluble H1F0 fractions
Correlate changes in phosphorylation with cell cycle progression using synchronized cell populations
This approach allows for detailed temporal analysis of H1F0 modifications throughout the cell cycle and can reveal specific phosphorylation sites that may regulate H1F0 function during different cellular processes .
Understanding how H1F0 interacts with chromatin remodeling complexes requires sophisticated experimental designs:
ChIP-seq with sequential immunoprecipitation: Use H1F0 (Ab-101) Antibody for the first IP followed by antibodies against chromatin remodeling complex components to identify regions of co-occupancy.
Proximity ligation assays: Detect physical interactions between H1F0 and remodeling complex components in situ within nuclei.
In vitro reconstitution systems: Combine purified H1F0 with nucleosomes and chromatin remodeling complexes to assess functional interactions.
CRISPR-Cas9 engineering: Create fusion proteins of H1F0 with proximity-dependent labeling enzymes (BioID or APEX2) to identify proteins in close proximity to H1F0 in living cells.
Research suggests that the highly dynamic nature of H1F0 on chromatin may facilitate access of remodeling complexes to their nucleosomal substrates, making this interplay crucial for understanding chromatin regulation .
Computational approaches have proven valuable for understanding H1F0-nucleosome interactions. Based on recent research, an effective modeling strategy involves:
Combining structure-based models for the nucleosomal core particle and the globular domain of H1F0 with a polymer-like representation of disordered histone tails
Encoding interactions between disordered regions and DNA using non-specific short-range and electrostatic interactions with appropriate screening terms to account for experimental ionic strength
Adjusting model parameters to maximize agreement between measured FRET efficiencies and those computed from simulation ensembles
Validating the model against multiple experimental datasets, including intra- and intermolecular FRET measurements